Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1
Asma Bourafai-Aziez,1 Mohammed Benabderrahmane,2 Hippolyte Paysant,3,4 Louis-Bastien Weiswald,3,4 Laurent Poulain,3,4 Ludovic Carlier,5 Delphine Ravault,5 Marie Jouanne,2 Gaël Coadou,1 Hassan Oulyadi,1 Anne-Sophie Voisin-Chiret,2 Jana Sopková-de Oliveira Santos,2 Muriel Sebban1 1Normandie Université...
Saved in:
Main Authors: | Bourafai-Aziez A (Author), Benabderrahmane M (Author), Paysant H (Author), Weiswald LB (Author), Poulain L (Author), Carlier L (Author), Ravault D (Author), Jouanne M (Author), Coadou G (Author), Oulyadi H (Author), Voisin-Chiret AS (Author), Sopková-de Oliveira Santos J (Author), Sebban M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
by: Wu D, et al.
Published: (2018) -
Deferasirox-induced acute liver failure
by: Nirali Sanghvi, et al.
Published: (2024) -
Update on the use of deferasirox in the management of iron overload
by: Ali Taher, et al.
Published: (2009) -
Duodenal perforation caused by deferasirox "case report"
by: Mohammmed Al Blooshi, et al.
Published: (2023) -
Deferasirox - a rarer cause of Fanconi syndrome
by: Iman Khan, et al.
Published: (2019)